Marimed (MRMD) Accounts Payables (2011 - 2026)

Marimed (MRMD) has reported Accounts Payables for 16 consecutive years, with $13.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables rose 17.2% year-over-year to $13.1 million in Q2 2026; TTM through Jun 2026 was $13.1 million, a 17.2% increase from a year earlier, with the FY2025 full-year figure at $14.6 million, up 10.59% from the prior year.
• Accounts Payables was $13.1 million for Q2 2026 at Marimed, down from $15.1 million in the prior quarter.
• Over five years, Accounts Payables peaked at $15.1 million in Q1 2026 and troughed at $4.7 million in Q1 2023.
• A 5-year average of $10.4 million and a median of $10.7 million in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables sank 43.87% in 2023 and surged 119.85% in 2024, its largest moves.
• Over 5 years, Accounts Payables stood at $6.6 million in 2022, then surged by 35.84% to $9.0 million in 2023, then surged by 46.53% to $13.2 million in 2024, then rose by 10.59% to $14.6 million in 2025, then decreased by 9.87% to $13.1 million in 2026.
• The last three Accounts Payables figures came in at $13.1 million (Q2 2026), $15.1 million (Q1 2026), and $14.6 million (Q4 2025), per Business Quant data.